Respiratory Infections News

A longer interval between doses of COVID-19 vaccine in children aged 5 to 11 years was associated with higher effectiveness against symptomatic infection, according to a real-world study published in Pediatrics.

A pediatric infectious disease expert made the case that the world needs a better pertussis vaccine.

An FDA advisory committee recommend the approval of two respiratory syncytial virus vaccines for older people, who are among the most susceptible to severe disease, hospitalization and death from the infection.

Urban families, Black and multiracial children and families with low socioeconomic status faced the highest rates of pediatric care disruption during the COVID-19 pandemic, a study found.

The FDA has issued emergency use authorization for the Lucira COVID-19 & Flu Test, the first over the counter at-home diagnostic test that can differentiate and detect influenza A and B, and SARS-CoV-2, the FDA announced in a press release.

Black and Hispanic individuals were more likely to experience long COVID-related symptoms and health problems compared with white individuals, according to a new study.

Pfizer presented data for the first time publicly Thursday on its maternal vaccine candidate for respiratory syncytial virus, which was granted priority review this week by the FDA.

Preliminary estimates published Thursday in MMWR and presented this week by the CDC indicate that this season’s influenza vaccine offered significant protection among all ages.

As the COVID-19 pandemic grew, so did the feeling that the field of ID might begin to attract more physicians, drawn by the important and rewarding work that was so suddenly in the public eye.

I grew up in Bangkok, where I saw first-hand the impact of cholera, dengue, malaria and other tropical diseases — and experienced the early waves of the seventh pandemic of cholera.